Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: A propensity score-adjusted seer analysis

Annals of Oncology

Volumn 23, Issue 9, 2012, Pages 2449-2457

  Choi, A H ^a   Barnholtz sloan, J S ^a   Kim, J A ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Kaplan Meier; Propensity score; Radiation therapy; Retroperitoneal sarcoma; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROPERITONEAL SARCOMA; THERAPY EFFECT;

EID: 84865566852     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr616     Document Type: Article

References (26)

1. Pawlik TM, Pisters PW, Mikula L et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or highgrade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 2006; 13: 508-517.
2. Klein J, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer-Verlag 1997.
3. Rosenbaum P, Rubin D. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985; 39: 33-38.
4. D'Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-2281.
5. Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 2008; 27: 2037-2049.
6. Surveillance, Epidemiology, and End Results (SEER) Program. Seer Limited-Use Record Description Cases Diagnosed in 1973-2006. Bethesda, MD: National Cancer Institute 2008.
7. Bonvalot S, Rivoire M, Castaing M et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009; 27: 31-37.
8. Chiappa A, Zbar AP, Bertani E et al. Primary and recurrent retroperitoneal soft tissue sarcoma: prognostic factors affecting survival. J Surg Oncol 2006; 93: 456-463.
9. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228: 355-365.
10. Nathan H, Raut CP, Thornton K et al. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system. Ann Surg 2009; 250: 970-976.
11. Stoeckle E, Coindre JM, Bonvalot S et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001; 92: 359-368.
12. Leslie S, Thiebaud P. Using propensity scores to adjust for treatment selection bias. Proceedings of the SAS® Global Forum 2007 Conference. Cary, NC: SAS Institute Inc. 2007.
13. Coca-Perraillon M. Matching with Propensity Scores to Reduce Bias in Observational Studies. Philadelphia, PA: North East SAS Users Group (NESUG) 2006.
14. Normand ST, Landrum MB, Guadagnoli E et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 2001; 54: 387-398.
15. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 2009; 28: 3083-3107.
16. Pierie JP, Betensky RA, Choudry U et al. Outcomes in a series of 103 retroperitoneal sarcomas. Eur J Surg Oncol 2006; 32: 1235-1241.
17. Ahmed MI, White M, Ekundayo OJ et al. A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study. Eur Heart J 2009; 30: 2029-2037.
18. Tseng WH, Martinez SR, Do L et al. Lack of survival benefit following adjuvant radiation in patients with retroperitoneal sarcoma: a SEER analysis. J Surg Res 2011; 168: e173-e180.
19. Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer 2006; 106: 1610-1616.
20. Zhou Z, McDade TP, Simons JP et al. Surgery and radiotherapy for retroperitoneal and abdominal sarcoma: both necessary and sufficient. Arch Surg 2010; 145: 426-431.
21. Alektiar KM, Hu K, Anderson L et al. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys 2000; 47: 157-163.
22. Krempien R, Roeder F, Oertel S et al. Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 2006; 65: 773-779.
23. Tepper JE, Suit HD, Wood WC et al. Radiation therapy of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1984; 10: 825-830.
24. Tzeng CW, Fiveash JB, Popple RA et al. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer 2006; 107: 371-379.
25. Zagar TM, Shenk RR, Kim JA et al. Radiation therapy in addition to gross total resection of retroperitoneal sarcoma results in prolonged survival: results from a single institutional study. J Oncol 2008; 2008: 824036.
26. Sindelar WF, Kinsella TJ, Chen PW et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg 1993; 128: 402-410.